HomePortfoliosWatchlistCommunityDiscoverScreener
Sign Up or Login
  • United States

U.S. Luxury Stock News

Home

Portfolios

Watchlist

Community

Discover

Screener
NYSE:PRIM
NYSE:PRIMConstruction

Primoris Services Corporation Just Beat EPS By 12%: Here's What Analysts Think Will Happen Next

February 28, 2025
A week ago, Primoris Services Corporation ( NYSE:PRIM ) came out with a strong set of full-year numbers that could...
NasdaqGS:LUNG
NasdaqGS:LUNGMedical Equipment

Pulmonx Full Year 2024 Earnings: Beats Expectations

February 28, 2025
Pulmonx ( NASDAQ:LUNG ) Full Year 2024 Results Key Financial Results Revenue: US$83.8m (up 22% from FY 2023). Net loss...
NYSE:NPO
NYSE:NPOMachinery

We Think Enpro's (NYSE:NPO) Healthy Earnings Might Be Conservative

February 28, 2025
Enpro Inc.'s ( NYSE:NPO ) recent earnings report didn't offer any surprises, with the shares unchanged over the last...
NYSE:BEPC
NYSE:BEPCRenewable Energy

How Good Is Brookfield Renewable Corporation (NYSE:BEPC), When It Comes To ROE?

February 28, 2025
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
NYSE:CNR
NYSE:CNROil and Gas

Weak Statutory Earnings May Not Tell The Whole Story For Core Natural Resources (NYSE:CNR)

February 28, 2025
A lackluster earnings announcement from Core Natural Resources, Inc. ( NYSE:CNR ) last week didn't sink the stock...
NYSE:BIO
NYSE:BIOLife Sciences

Some Confidence Is Lacking In Bio-Rad Laboratories, Inc. (NYSE:BIO) As Shares Slide 28%

February 28, 2025
Bio-Rad Laboratories, Inc. ( NYSE:BIO ) shares have had a horrible month, losing 28% after a relatively good period...
NYSE:PFE
NYSE:PFEPharmaceuticals

Market Still Lacking Some Conviction On Pfizer Inc. (NYSE:PFE)

February 28, 2025
It's not a stretch to say that Pfizer Inc.'s ( NYSE:PFE ) price-to-earnings (or "P/E") ratio of 18.4x right now seems...
NYSE:FSLY
NYSE:FSLYIT

Fastly Full Year 2024 Earnings: EPS Beats Expectations

February 28, 2025
Fastly ( NYSE:FSLY ) Full Year 2024 Results Key Financial Results Revenue: US$543.7m (up 7.4% from FY 2023). Net loss...
NasdaqGS:RBB
NasdaqGS:RBBBanks

Independent Director of RBB Bancorp James W. Kao Buys 1.7% More Shares

February 28, 2025
Investors who take an interest in RBB Bancorp ( NASDAQ:RBB ) should definitely note that the Independent Director...
NYSE:SDHC
NYSE:SDHCConsumer Durables

Insider Buyers Lose US$72k As Smith Douglas Homes Sheds US$21m

February 28, 2025
Insiders who bought US$256.2k worth of Smith Douglas Homes Corp.'s ( NYSE:SDHC ) stock at an average buy price of...
NYSE:TIXT
NYSE:TIXTProfessional Services

TELUS International (Cda) Inc. (NYSE:TIXT) Not Doing Enough For Some Investors As Its Shares Slump 25%

February 28, 2025
TELUS International (Cda) Inc. ( NYSE:TIXT ) shareholders that were waiting for something to happen have been dealt a...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

Intellia Therapeutics Full Year 2024 Earnings: Beats Expectations

February 28, 2025
Intellia Therapeutics ( NASDAQ:NTLA ) Full Year 2024 Results Key Financial Results Revenue: US$57.9m (up 60% from FY...
NasdaqCM:HRTX
NasdaqCM:HRTXBiotechs

Heron Therapeutics (NASDAQ:HRTX) shareholders are up 19% this past week, but still in the red over the last five years

February 28, 2025
It is a pleasure to report that the Heron Therapeutics, Inc. ( NASDAQ:HRTX ) is up 72% in the last quarter. But spare a...
NYSE:PG
NYSE:PGHousehold Products

This Insider Has Just Sold Shares In Procter & Gamble

February 28, 2025
We wouldn't blame The Procter & Gamble Company ( NYSE:PG ) shareholders if they were a little worried about the fact...
NYSE:NATL
NYSE:NATLDiversified Financial

NCR Atleos Corporation's (NYSE:NATL) Share Price Is Matching Sentiment Around Its Revenues

February 28, 2025
With a price-to-sales (or "P/S") ratio of 0.5x NCR Atleos Corporation ( NYSE:NATL ) may be sending very bullish signals...
NYSE:GRBK
NYSE:GRBKConsumer Durables

Green Brick Partners Full Year 2024 Earnings: EPS Beats Expectations

February 28, 2025
Green Brick Partners ( NYSE:GRBK ) Full Year 2024 Results Key Financial Results Revenue: US$2.10b (up 18% from FY...
NasdaqGS:MLAB
NasdaqGS:MLABLife Sciences

At US$135, Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Worth Looking At Closely?

February 28, 2025
Mesa Laboratories, Inc. ( NASDAQ:MLAB ), might not be a large cap stock, but it saw a significant share price rise of...
NasdaqGS:FWRD
NasdaqGS:FWRDLogistics

Forward Air Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

February 28, 2025
Forward Air ( NASDAQ:FWRD ) Full Year 2024 Results Key Financial Results Revenue: US$2.47b (up 81% from FY 2023). Net...
NasdaqGM:AMTX
NasdaqGM:AMTXOil and Gas

Aemetis, Inc. (NASDAQ:AMTX) Is Expected To Breakeven In The Near Future

February 28, 2025
We feel now is a pretty good time to analyse Aemetis, Inc.'s ( NASDAQ:AMTX ) business as it appears the company may be...
NasdaqGS:PENN
NasdaqGS:PENNHospitality

PENN Entertainment Full Year 2024 Earnings: EPS Misses Expectations

February 28, 2025
PENN Entertainment ( NASDAQ:PENN ) Full Year 2024 Results Key Financial Results Revenue: US$6.58b (up 3.4% from FY...
NasdaqGS:CCCC
NasdaqGS:CCCCBiotechs

C4 Therapeutics Full Year 2024 Earnings: EPS Beats Expectations

February 28, 2025
C4 Therapeutics ( NASDAQ:CCCC ) Full Year 2024 Results Key Financial Results Revenue: US$35.6m (up 71% from FY 2023...
NasdaqGS:SATS
NasdaqGS:SATSMedia

EchoStar Full Year 2024 Earnings: EPS Beats Expectations

February 28, 2025
EchoStar ( NASDAQ:SATS ) Full Year 2024 Results Key Financial Results Revenue: US$15.8b (down 7.0% from FY 2023). Net...
NasdaqCM:ZENV
NasdaqCM:ZENVSoftware

Zenvia Inc. (NASDAQ:ZENV) CEO Cassio Bobsin Machado, the company's largest shareholder sees 14% reduction in holdings value

February 28, 2025
Key Insights Significant insider control over Zenvia implies vested interests in company growth A total of 2 investors...
NYSE:ARIS
NYSE:ARISEnergy Services

Should You Be Adding Aris Water Solutions (NYSE:ARIS) To Your Watchlist Today?

February 27, 2025
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Last
  • 859
  • 860
  • 861
  • 862
  • 863
Next

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.

Level 5, 320 Pitt Street, Sydney
S&P Global Market Intelligence

Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2025, S&P Global Market Intelligence LLC. All rights reserved.

View Data Sources

Markets

  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE

Investing Ideas

  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence

Features

  • Portfolio Tracker
  • Screener
  • Investing Ideas
  • Community Narratives
  • Market Insights
  • What's New

Simply Wall St

  • Plans
  • About Us
  • Our People
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

© 2025 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206

Financial Services GuideTerms and ConditionsPrivacy Policy